These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 12478085
1. Rituximab and chemotherapy is highly effective in patients with CD20-positive non-Hodgkin's lymphoma and HIV infection. Spina M, Sparano JA, Jaeger U, Rossi G, Tirelli U. AIDS; 2003 Jan 03; 17(1):137-8. PubMed ID: 12478085 [No Abstract] [Full Text] [Related]
2. Rituximab for HIV-associated lymphoma: weighing the benefits and risks. Spina M, Tirelli U. Curr Opin Oncol; 2005 Sep 03; 17(5):462-5. PubMed ID: 16093796 [Abstract] [Full Text] [Related]
3. Intensive chemotherapy with rituximab is safe and effective in AIDS non-Hodgkin's lymphoma. Rey J, Charbonnier A, Schiano de Colella JM, Stoppa AM, Poizot-Martin I, Gastaut JA, Costello RT. AIDS; 2003 Sep 05; 17(13):2006-7. PubMed ID: 12960844 [No Abstract] [Full Text] [Related]
4. Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy. Maeshima AM, Taniguchi H, Nomoto J, Maruyama D, Kim SW, Watanabe T, Kobayashi Y, Tobinai K, Matsuno Y. Cancer Sci; 2009 Jan 05; 100(1):54-61. PubMed ID: 19038008 [Abstract] [Full Text] [Related]
5. [Results of dose-intense, dose-impact weekly combination chemotherapy with rituximab for patients with CD 20-positive B-cell non-Hodgkin's lymphoma]. Uzuka Y, Saitou Y, Saitou K, Suzuki S, Yamaguchi M. Gan To Kagaku Ryoho; 2007 Jul 05; 34(7):1085-90. PubMed ID: 17637545 [Abstract] [Full Text] [Related]
7. [Clinical observation of Rituximab in a CD20+B non-Hodgkin's lymphoma]. Hao LC, Zhang LZ. Zhonghua Er Ke Za Zhi; 2003 Aug 05; 41(8):627. PubMed ID: 14744396 [No Abstract] [Full Text] [Related]
12. Successful treatment of aggressive HIV-associated non-Hodgkin's lymphoma with combination chemotherapy, biotherapy with rituximab and HAART: presentation of a therapeutic option. Klepfish A, Schattner A, Shvidel L, Shtalrid M, Haran M, Bentwich Z, Berrebi A. Leuk Lymphoma; 2003 Feb 05; 44(2):349-51. PubMed ID: 12688356 [Abstract] [Full Text] [Related]
13. Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma. Cheson BD, Leonard JP. N Engl J Med; 2008 Aug 07; 359(6):613-26. PubMed ID: 18687642 [No Abstract] [Full Text] [Related]
14. Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment. Davis TA, Grillo-López AJ, White CA, McLaughlin P, Czuczman MS, Link BK, Maloney DG, Weaver RL, Rosenberg J, Levy R. J Clin Oncol; 2000 Sep 07; 18(17):3135-43. PubMed ID: 10963642 [Abstract] [Full Text] [Related]
19. Lymphocyte subsets and viral load in patients with HIV-associated non-Hodgkin's lymphoma treated with anti-CD20 monoclonal antibody and chemotherapy. De Paoli P, Vaccher E, Tedeschi R, Caffau C, Zanussi S, Bortolin MT, Crepaldi C, Spina M, Tirelli U. Cancer Immunol Immunother; 2001 May 07; 50(3):157-62. PubMed ID: 11419183 [Abstract] [Full Text] [Related]
20. Chlorambucil - rituximab as first line combination therapy in follicular non-Hodgkin's lymphoma: a clinical and biological analysis. Laszlo D, Rabascio C, Andreola G, Pruneri G, Raia V, Calabrese L, Radice D, Saronni L, Martinelli G. Leuk Lymphoma; 2007 Feb 07; 48(2):437-8. PubMed ID: 17325914 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]